Clinical Trial

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the safety and pharmacokinetic characteristics of DWJ1622, DWC202313, and DWC202314 in healthy adult volunteers under fasting conditions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-21.
Trial Details
NCT Number NCT07260851
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Healthy Volunteers
Enrollment 40 participants
Start Date 2025-11-05
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-17